LobbyingData.com Logo

Grifols S.A. (GRFS) all U.S. Lobbying: all historical lobbying contracts, government bills & agencies, and critical issues lobbied on.


Discover Grifols Inc’s lobbying activities with our comprehensive dataset, offering insights on spending, bills, and issues from 1999-present. Analyze data by company, lobbyist, issue, and more through our intelligently crafted data design. Dataset updated weekly.


Using our intelligently designed and intuitive dataset, you can quickly understand how Grifols S.A. (GRFS) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.

Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.

For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.

Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.

Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:

1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.

2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.

3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).

4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.

5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).

6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).

7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).

Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].

Frequently Asked Questions

What is Grifols S.A. (GRFS) lobbying for?

Summary of lobbying data: Grifols Inc hired the lobbying firm Sidley Austin Llp to lobby on general issues such as taxation/internal revenue code, Medicare/Medicaid, and health issues. They lobbied on specific issues including various legislative proposals that would amend the drug-discount program under Section 340B of the Public Health Services Act, healthcare deficit reduction proposals, IVIG access, and expansion, and commentary on the AMP rule. They lobbied various government agencies including the House of Representatives, Department of Treasury, Department of Health & Human Services, Senate, Health Resources & Services Administration, and Centers for Medicare and Medicaid Services.

One could infer that Grifols Inc is lobbying on these issues to protect and promote their interests as a healthcare company that develops, manufactures, and markets plasma-derived therapies. The issues they lobbied on, such as Medicare/Medicaid and healthcare reform, directly impact their business and profitability. Lobbying on specific legislative issues related to the drug-discount program under Section 340B and advocating for IVIG access and expansion could also help Grifols Inc secure a larger market share and revenue. Overall, their lobbying efforts seem to be aimed at protecting and advancing their business interests in the healthcare industry.

Subscribe To Our Newsletter

gain actionable insights from our alternative data

More to explore